Single foetal haemoglobin inducer at any dose or duration vs another dose or dose regimen of the same foetal haemoglobin inducer
Thrombocytopenia (platelet count < 50 × 103/μL) · people with non‐transfusion‐dependent β‐thalassaemia
It is very uncertain whether one dose or dose regimen of a foetal haemoglobin inducer changes thrombocytopenia (platelet count < 50 × 103/μL) compared with another dose or dose regimen of the same foetal haemoglobin inducer (very low certainty).
1 finding from 1 review
- Foetal haemoglobin inducers for reducing blood transfusion in non‐transfusion‐dependent beta‐thalassaemias 2023 · Cochrane Headline outcomes onlyRR 3.68 [1.12, 12.07]1 study · 61 participantsVery low